Navigation Links
Overcoming Challenges in Amblyopia Detection using Visual Evoked Potential (VEP)
Date:7/30/2012

PINE BROOK, N.J., July 30, 2012 /PRNewswire/ -- Vision Problems in infants and pre-verbal children are a challenge for ophthalmologists and optometrists to diagnose and manage. Many vision tests look at just the structure of the eye or require a verbal response which many children are either unable or unwilling to give. Dr. Sean Donahue and colleagues at Vanderbilt Eye Institute in Nashville, TN recently presented a poster, Visually Evoked Potential Detection of Amblyopia in the Clinic, at the annual American Association for Pediatric Ophthalmology and Strabismus (AAPOS) meeting. Their research helps provide a solution to eye care specialists for their pediatric patients.

Office-based visual evoked potential (VEP) technology from Diopsys, Inc. allows eye care professionals to objectively measure the function of the entire visual pathway without the patient having to say a word. VEPs are electrical signals ("brain waves") that are measured at the visual cortex. VEPs occur when a patient observes a visual stimulus, such as a flash of light or a pattern on a monitor. VEP results are a representation of the functional integrity of the visual system including the retina, optic nerve, optic radiations, and visual cortex.

Dr. Donahue used this technology to develop a user and patient friendly test to aide in the diagnosis and management of amblyopia in children. He describes amblyopia as "poor vision in an eye that otherwise appears normal and occurs when the brain does not recognize the sight from that eye. Eventually, the brain stops using the weaker eye, causing poor vision or even permanent visual impairment."

By testing both normal children and children with amblyopia with the Diopsys® NOVA-TR system, researchers found that a simple 5-minute VEP protocol correctly identified children with amblyopia more than 80% of the time. "This is important since fixation preference testing can be unreliable in detecting amblyopia in preverbal children," said Dr. Donahue. Additionally, the researchers found that this testing method correctly identified normal patients nearly 94% of the time, and could also help classify patients with amblyopia as "mild" or "moderate to severe."  This study was so successful the poster went on to win "Best in Show" at the meeting.

The Diopsys® NOVA-TR VEP Vision Testing System is easy to use, non-invasive, and testing times are flexible and depend upon the customized settings designated by the clinician. Automation of the test protocol used for the study, the Diopsys® NOVA-PED, is currently under development and is projected to be available later this year.

Diopsys, Inc. (www.diopsys.com) is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care solutions. The company specializes in the development and marketing of patient-friendly, non-invasive vision testing equipment utilizing Visual Evoked Potential (VEP) technology.


'/>"/>
SOURCE Diopsys, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Biomedical Device Industry in America: Challenges at Home and Abroad
2. Pharma Execs Continue Looking For Growth Opportunities In Spite Of Increasing Regulatory Challenges: KPMG Survey
3. International Drug & Explosives Detection Company Identa Corp to Dispatch First Order to Drug Store Chain
4. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
5. Trovagene to Study Trans-Renal KRAS Mutation Detection in Pancreatic Cancer
6. Breast Cancer Detection and Treatment Recovers Slowly from Big Losses During Recession
7. ChemDAQ Releases First Sensor For Detection Of Peracetic Acid In Air
8. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
9. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
10. Largest Public Hospital in Sydney Delivers First Treatment in Australia Using Advanced TrueBeam Radiotherapy and Radiosurgery Device
11. Partnership Aims to Prevent Students from Misusing Prescription Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the ... Strategies" report to their offering. ... Pain Management in the ... their physical pain, emphasizing consumer survey analysis, including trends over ... adults who have selected illnesses/conditions strongly associated with physical pain ...
(Date:3/24/2017)... 24, 2017 ShangPharma, a leading ... cost-effective drug development and discovery services, technology, ... industry, announced today the intent for a ... be consolidating the Contract Research Organizations (CRO) ... ChemPartner. These entities include ChemPartner Shanghai, ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology:
(Date:3/24/2017)... , ... March 24, 2017 , ... ... Society (ONS) wanted to create a communications platform that positions them as the ... Elliance and ONS reinvented their online publication as an always-on, always-fresh news, views ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro ... their partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is ... Ave., Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation ... and college Bible teacher residing in North Carolina with his wife, Anna Marie. He ... them with six grandchildren. David is also the author of “Shadow and Substance.” , ...
(Date:3/23/2017)... ... 2017 , ... The physicians of KSF Orthopaedic Center PA are proud to ... location is located at 2255 E. Mossy Oaks Rd., Suite 440, Spring, Texas 77389 ... provide patients living in the north Houston area (The Woodlands, Conroe, Magnolia, Kingwood, Humble) ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The MBI “Hall of Fame” recognizes the ... acts have had a significant impact on the careers of all others involved. ... Inc. was inducted into the MBI’s Hall of Fame. The induction took place during ...
Breaking Medicine News(10 mins):